NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs

NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs

Prostate cancer (PCa) is the most frequently diagnosed cancer in men and second most common cause of cancer-related deaths in the United States. Androgen deprivation therapy (ADT) is only temporarily effective for advanced-stage PCa, as the disease inevitably progresses to castration-resistant prost...

Full description

Bibliographic Details
Main Authors: Tyler Sheetz, Joseph Mills, Anna Tessari, Megan Pawlikowski, Ashley E. Braddom, Tasha Posid, Debra L. Zynger, Cindy James, Valerio Embrione, Kareesma Parbhoo, Claudia Foray, Vincenzo Coppola, Carlo M. Croce, Dario Palmieri
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
nucleolin
microRNAs
prostate cancer
castration-resistant prostate cancer
Online Access:https://www.mdpi.com/2072-6694/12/7/1861

Internet

https://www.mdpi.com/2072-6694/12/7/1861

Similar Items